Difficult to Treat Asthma : Clinical Essentials (Respiratory Medicine)

個数:

Difficult to Treat Asthma : Clinical Essentials (Respiratory Medicine)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 334 p.
  • 言語 ENG
  • 商品コード 9783030208141
  • DDC分類 610

Full Description

This book provides a practical, stepwise, evidence-based approach to effective management of patients with difficult to treat asthma. The impact of asthma on morbidity and healthcare utilization increases exponentially with severity. Severe refractory asthma accounts for less than 5% of all asthma. Its prevalence, however, is often overestimated as there are several other confounding factors that make asthma 'difficult to treat'. Many novel (albeit expensive) therapies are now available and providers caring for patients with severe asthma are charged with selecting the best evidence treatment. This calls for complex and nuanced decision-making. Whether people with asthma gain and maintain control over their condition depends not only on the availability of effective drugs, but also multiple patient and healthcare provider behaviors. Therefore, now more than ever, it has become increasingly important to differentiate "difficult" from "severe refractory" asthma to allow identification of patients most likely to benefit from these therapies.  This volume delves into the current understanding of mechanisms and increasingly recognized heterogeneity of this complex disease. It discusses a structured approach to identification and optimization of factors contributing to poor asthma control, including nonadherence, comorbidities and occupational/environmental triggers. The book includes 'state of the art' reviews on recent advances in traditional and targeted asthma therapies, as well as a glimpse into what the future may hold. Highlights include a comprehensive guide to management of severe asthma in children and pregnancy, as well as practical considerations to management of asthma based on different clinical phenotypes. Each chapter is authored by leading experts in the field who share their own clinical approach.  This is an ideal guide for clinical pulmonologists and allergist/immunologists, as well as primary care providers, physician extenders in specialty practice, physicians in pulmonary/allergy training, and even industry partners.  

Contents

Scope of the problem, definition and pathophysiology.- Is it Asthma? Recognizing asthma mimics.- Beyond Refills: Promoting Adherence to Optimize Outcomes.- Addressing Comorbidities in Difficult Asthma.- Evaluation and Management of Work-Related Asthma.- Advances in Inhaled Medications.- Heterogeneity in Severe asthma.- Biomarkers, Targeted Therapies, Biologics and Bronchial Thermoplasty.- Practical Considerations in Management of Allergic Asthma.- Practical considerations in the management of eosinophilic asthma.- Practical considerations in management of non-eosinophilic asthma.- Practical considerations in management of obesity associated asthma.- Severe asthma in pregnancy: Special considerations.- Severe asthma in childhood: Special considerations.- High-risk asthma clinic: Putting it all together.- Difficult Asthma: Unmet Needs and Future Directions. 

最近チェックした商品